Hopp til innhold

Article

Live map of COVID-19 evidence

Published Updated

A growing number of studies and reports are being published on COVID-19 and the pandemic. This project will help decision makers and researchers navigate the research.

Nytt forskningskart med logoer downsized.png

A growing number of studies and reports are being published on COVID-19 and the pandemic. This project will help decision makers and researchers navigate the research.


We provide an overview of scientific publications on COVID-19 categorized and parsed into more specific subgroups, providing quick access to specific topic-relevant publications. As a result, the map also identifies research gaps, possibly guiding further research efforts. Our partner at McMaster University, Canada is making an evidence map of trustworthy guidelines.

We receive studies that EPPI Centre has screened after searching weekly in Medline and Embase. We supplement these studies with a weekly search in Scopus.

We update the map every other week.

As of 24 June 2020 the map contains 4,363 publications categorised by topic, population, and publication type. Together with EPPI Centre, we have screened 24,328 references retrieved through our searches. The map includes all systematic reviews, RCTs, non-randomised studies with control groups, and method papers identified up to 25 May 2020. For non-randomised studies without control groups, qualitative studies, and protocols, the map is up-to-date until 4 May 2020.

The main map gives an overview of all publications categorized according to publication type, population of interest and topic. User guides can be found in the «About»-section on the top left of each screen.

More detailed maps are available for these topics:

Reviews on Covid-19

Contact us

Do you have questions or comments? Please contact us at Covid-19.evidencemap@fhi.no

Call for collaboration

We are seeking agencies and individual contributors interested in collaborating on this live map of COVID-19 evidence. Specifically, we are looking for partners that want to engage in the categorization of COVID-19 studies or in the risk of bias appraisal of prioritized studies. A complete call for collaboration is available.